Nutritional Status Study of Inpatients in Hospitals

evaluating the nutritional status of inpatients with 7 catogories of diseases ( including digestive system, respiratory system, cardiovascular and endocrine system, tumor, nervous system, urinary system) within 24~48 hours after admission. Among them, the Second Affiliated Hospital of Zhejiang University School of Medicine has undertaken 200 cases, and a total of 25 hospitals in zhejiang participated（5000 cases in total）.

Study Overview

• Status: Completed
• Conditions: Nutritional Status
• Intervention / Treatment: Other: Cross-sectional obeservational survey

• Study Type: Observational
• Enrollment (Actual): 5000

Contacts and Locations

Study Locations

• China
  • Zhejiang
    • Hangzhou, Zhejiang, China, 310009
      • 2nd Affiliated Hospital, School of Medicine, Zhejiang University

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

adult inpatients with within 7 categories of diseases (including digestive system, respiratory system, cardiovascular and endocrine system, tumor, nervous system, and urinary system)

Description

Inclusion Criteria:

• Inpatients with 7 categories of diseases (including digestive system, respiratory system, cardiovascular and endocrine system, tumor, nervous system, and urinary system)
• Age ≥ 18
• 24～48h after admission

Exclusion Criteria:

• Age<18
• Critically ill patient
• With mental illness and cannot think or behavior normally
• Any other serious or uncontrolled illness which the investigator think is undesirable for the patient to enter the trial

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
adult inpatients; adult inpatients with 7 categories of diseases (including digestive system, respiratory system, cardiovascular and endocrine system, tumor, nervous system, and urinary system)	Other: Cross-sectional obeservational survey; Cross-sectional obeservational survey

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Nutritional risk screening scored with NRS 2002 questionnaire	Detect the presence of undernutrition and the risk of developing undernutrition by Risk Screening 2002 questionnaire(NRS-2002) . The overall score range is from 0 to 7, when score≥3, the patient is nutritionally at-risk	24~48 hours after admission

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Body fat mass	Body Fat Mass is assessed by bioelectrical impedance analysis (BIA)	24~48 hours after admission
Body muscle mass	Body muscle mass is assessed by bioelectrical impedance analysis (BIA)	24~48 hours after admission

Collaborators and Investigators

• Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Collaborators: Zhejiang University; Sir Run Run Shaw Hospital; Red Cross Hospital, Hangzhou, China; Zhejiang Provincial People's Hospital; The First People's Hospital of Huzhou; Jinhua Municipal Central Hospital; The Central Hospital of Lishui City; First Affiliated Hospital of Wenzhou Medical University; Shaoxing People's Hospital; Yuyao People' s Hospital; Jinhua People' s Hospital; Lishui People' s Hospital; Ningbo No. 1 Hospital; Huizhou Municipal Central Hospital; Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University; Zhejiang Provincial Tongde Hospital; The First People's Hospital of Wenling; Zhejiang Hospital; Cancer Hospital of The University of Chinese Academy of Sciences; The Second Affiliated and Yuying Children's Hospital of Wenzhou Medical University; Quzhou People' s Hospital; The First People's Hospital of Yongkang

Study record dates

Study Major Dates

• Study Start (Actual): October 1, 2020
• Primary Completion (Actual): March 30, 2021
• Study Completion (Actual): March 30, 2021

Study Registration Dates

• First Submitted: May 31, 2021
• First Submitted That Met QC Criteria: June 9, 2021
• First Posted (Actual): June 10, 2021

Study Record Updates

• Last Update Posted (Actual): July 22, 2021
• Last Update Submitted That Met QC Criteria: July 17, 2021
• Last Verified: April 1, 2021

More Information

Terms related to this study

• Other Study ID Numbers: 2020-928

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No